4.1 Article

Association between pan-immune-inflammation value and no-reflow in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Peripheral Vascular Disease

Increased Serum Systemic Immune-Inflammation Index is Independently Associated With Severity of Carotid Artery Stenosis

Saban Kelesoglu et al.

Summary: This study investigated the use of the systemic immune inflammation index (SII) to predict the likelihood of developing carotid artery stenosis (CAS). The results showed that an increase in SII is independently associated with the severity of CAS.

ANGIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention

Kerim Esenboga et al.

Summary: SII levels are independently associated with the occurrence of no-reflow phenomenon in patients undergoing primary PCI for acute STEMI. High SII may serve as a promising indicator for predicting no-reflow phenomenon in these patients.

ACTA CARDIOLOGICA (2022)

Article Peripheral Vascular Disease

Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients With Cardiac Syndrome X

Erdogan Yasar et al.

Summary: The systemic immune inflammation index (SII) is a new marker that predicts microvascular dysfunction in patients with Cardiac Syndrome X (CSX).

ANGIOLOGY (2022)

Article Oncology

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer

Fei Lin et al.

Summary: A simple scoring system based on immune and inflammatory parameters has been established and validated to predict postoperative survival in patients with operable breast cancer. The system, utilizing the pan-immune-inflammation value (PIV), is able to predict survival outcomes by evaluating several independent prognostic parameters. This scoring model shows promising accuracy and can assist clinicians in implementing tailored treatment strategies for breast cancer patients.

FRONTIERS IN ONCOLOGY (2022)

Article Cardiac & Cardiovascular Systems

A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index

Murat Gok et al.

Summary: The study found a positive correlation between SII levels and the severity of APE, with higher SII levels associated with massive APE. SII can serve as an independent predictor for massive APE, making it a more powerful tool than traditional inflammatory markers in predicting disease severity in these patients.

SCANDINAVIAN CARDIOVASCULAR JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study

Yiyang Tang et al.

Summary: In critically ill patients with CHF, a high level of SII effectively predicts high 30- and 90-day and hospital mortalities, as well as a high risk of occurrence of MACEs. However, there is no significant correlation between SII and readmission rate.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Oncology

The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab

Francesca Ligorio et al.

Summary: The Pan-Immune-Inflammatory Value (PIV) in peripheral blood may serve as a new and powerful predictor of overall survival in HER2+ advanced breast cancer patients treated with first-line trastuzumab-pertuzumab-containing biochemotherapy, potentially improving prognostic stratification in this patient population.

CANCERS (2021)

Article Medicine, Research & Experimental

Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention

Qiang Su et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2018)

Review Medicine, Research & Experimental

Cytokine networking of innate immunity cells: a potential target of therapy

Ilja Striz et al.

CLINICAL SCIENCE (2014)

Review Immunology

Thrombosis as an intravascular effector of innate immunity

Bernd Engelmann et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Review Cardiac & Cardiovascular Systems

Myocardial No-Reflow in Humans

Giampaolo Niccoli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Review Cardiac & Cardiovascular Systems

Coronary No-Reflow Phenomenon: From the Experimental Laboratory to the Cardiac Catheterization Laboratory

Shereif H. Rezkalla et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2008)

Editorial Material Cardiac & Cardiovascular Systems

Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention

Ronen Jaffe et al.

CIRCULATION (2008)

Review Cardiac & Cardiovascular Systems

No-reflow phenomenon and prognosis in patients with acute myocardial infarction

Hiroshi Ito

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)